Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Price History
|
Ratios
|
Insiders
Bullboard - Stock Discussion Forum
Telo Genomics Corporation
V.TELO
Alternate Symbol(s):
TDSGF
Healthcare
Industrials
Diagnostics & Research
Conglomerates
Telo Genomics Corp., a molecular diagnostics company, engages in the development and commercialization of predictive technological products to personalize treatment plans for patients with specific conditions, primarily in Canada. The company’s TeloView platform measures the 3D structure and spatial organization of telomeres to inform on genetic and molecular characteristics that are predictive...
of genomic instability, identify specific disease mechanisms, predict disease risks, and determine effective treatments. Its lead product is TeloView-SMM (Smoldering Multiple Myeloma) for SMM patients with a high risk of transition to multiple myeloma (MM). The company also develops TeloView NDMM, which predicts newly diagnosed MM patients who may relapse on first-line therapy; TeloMRD-D, which identifies and enumerates MRD cells in post-transplant patients; and TeloViewNG-MRD (Minimal Residual Disease) Profiling for genomic instability profiling of MRD-detected cells in post-transplant patie...
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Bullboard (TSXV:TELO)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
Next
(16)
•••
mangle
X
Post by
mangle
on Sep 29, 2025 5:10pm
Great product
Terrible investment. So sad
(61)
•••
bmreed
X
Comment by
bmreed
on Nov 20, 2023 12:56pm
RE:Webinar $TELO CEO Kris Weinberg Nov 21st @ 1PM ET / 10AM PT
This webinar has been post-poned. When the recheduled date has been confirmed we will post it to this board. Thank you for your understanding.
(61)
•••
bmreed
X
Post by
bmreed
on Nov 17, 2023 5:29pm
Webinar $TELO CEO Kris Weinberg Nov 21st @ 1PM ET / 10AM PT
Live Webinar - Telo Genomics Corp $TELO w/ CEO Kris Weinberg Tuesday, November 21st at 1PM ET / 10AM PT Q&A with Radius Research Register Here - https://us02web.zoom.us/webinar
...more
(0)
•••
lance1997
X
Post by
lance1997
on Aug 06, 2023 7:03am
August
Phase 1 should be ongoing now.
(0)
•••
westdakotadave
X
Post by
westdakotadave
on May 17, 2023 10:46am
82% Accurate Blood Test
$TDSGF $TELO.V 82% Accurate Blood Test SEE: European Hematology Association Abstract P975 https://library.ehaweb.org/eha/2023/eha2023-congress/386804/shaji.kumar
...more
(0)
•••
westdakotadave
X
Post by
westdakotadave
on May 17, 2023 10:44am
TeloGenomics Mayo Abstract
$TDSGF $TELO.V TeloGenomics Mayo Clinic results presented at ASCO. https://meetings.asco.org/abstracts-presentations/226578
(0)
•••
westdakotadave
X
Post by
westdakotadave
on Apr 18, 2023 12:13pm
$TDSGF Mayo Clinic Results
$TELO.V $TDSGF The Mayo Clinic study "has exceeded its targeted endpoints". See 9/14/2022 Press Release.
(0)
•••
westdakotadave
X
Post by
westdakotadave
on Apr 15, 2023 3:23pm
TeloGenomics @ ASCO with approved Abstract
It is at ASCO at Booth IH18 from June 2-6, 2023 not at ASH as posted befoere this.
(0)
•••
westdakotadave
X
Post by
westdakotadave
on Apr 15, 2023 3:21pm
TeloGenomics @ASCO
ASCO Abstract approved for release and publication. See Telo Genomics at Booth 3243 at ASH 2022 Conference.
(0)
•••
westdakotadave
X
Post by
westdakotadave
on Mar 21, 2023 11:10am
$TDSGF
$TDSGF Telo Genomics at Booth IH18 from June 2-6, 2023 at American Society of Clinical Oncology (ASCO).
(0)
•••
westdakotadave
X
Post by
westdakotadave
on Mar 17, 2023 2:12pm
$TDSGF GAMEPLAN
$TDSGF GAMEPLAN per Feb 28, 2023 Filing (SEDAR MD&A) March 2023 = Mayo SMM results have been submitted to the American Society of Clinical Oncology (ASCO) for presentation. June 2023
...more
(0)
•••
westdakotadave
X
Post by
westdakotadave
on Nov 01, 2022 1:02pm
TELO Abstract
American Society of Hematology (ASH) Abstract Schedule Abstracts available online November 3, 2022, 9:00 a.m. Eastern time Late-breaking abstracts available online November 22, 2022. ASH ANNUAL
...more
(3)
•••
toasted101
X
Post by
toasted101
on Jul 13, 2022 6:26pm
Telo Clinical Study of Drug Resistance for Multiple Myeloma
Telo Genomics Launches Clinical Study of Drug Resistance Test for Multiple Myeloma Toronto, Ontario--(Newsfile Corp. - July 13, 2022) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the
...more
(21)
•••
bandi10
X
Post by
bandi10
on Jul 07, 2022 12:18pm
news
Telo Genomics Completes Processing and Analysis of Smoldering Multiple Myeloma Patient Samples Toronto, Ontario--(Newsfile Corp. - July 6, 2022) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF
...more
(3)
•••
toasted101
X
Post by
toasted101
on May 31, 2022 10:04am
Telo Announces Validation of Its Proprietary Tools for SMM
Telo Genomics Announces Successful Validation of Its Proprietary Automation Tools for Smoldering Multiple Myeloma Toronto, Ontario--(Newsfile Corp. - May 31, 2022) - Telo Genomics Corp. (TSXV
...more
Prev
1
2
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
{{previousButtonTitle}}
{{nextButtonTitle}}
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
A Company Focused on Developing Functional Healthier “Better For You” Foods
Building Momentum in One of the World's Most Prospective Copper Regions
Sorrento Resources Provides Update on Exploration on Rodgers Cove Project, Newfoundland
A tungsten producer and developer in Portugal, South Korea & Spain on track to become a top supplier
DiagnosTear Announces Clinical Study to Advance Analytical Validation & FDA Submission Pathway of TeaRx(TM)